Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases.
DNDi is working on the following diseases:
- Sleeping Sickness (human African trypanosomiasis)
- Chagas disease
- Paediatric HIV
- Filarial diseases
- Hepatitis C
In 2015, DNDi handed over its Malaria portfolio.
To learn more about DNDi‘s activities and patients download our short Presentation Brochure!